EntryPoint Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
EntryPoint Capital's IDXX Position: Q2 2026 in Review
EntryPoint Capital reduced its Idexx Laboratories (IDXX) stake by 57% in Q2 2026, selling an estimated $478K and leaving 635 shares worth $334K. The position accounts for 0.08% of the portfolio, ranked #499.
EntryPoint Capital first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $836K in Q1 2026. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- EntryPoint Capital held 635 shares of Idexx Laboratories worth $334K as of Q2 2026.
- EntryPoint Capital sold 853 Idexx Laboratories shares in Q2 2026, an estimated $478K.
- Idexx Laboratories made up 0.08% of EntryPoint Capital's portfolio in Q2 2026, its #499 holding.
- EntryPoint Capital first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
- EntryPoint Capital's Idexx Laboratories position peaked at $836K in Q1 2026.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.